menu
    • menu

    Company profile for Kleo Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kleo is based in New Haven, CT and was founded in 2016 by Dr. David Spiegel and Roy Prieb to translate Dr. Spiegel's research in small molecule immunotherapies at Yale University into clinical treatments. Kleo’s mission is to create fully synthetic compounds that recruit the immune system to destroy cancer cells, but with significant advantages compared to biologics. Kleo’s unique technologies are scientifically validated ...
    Kleo is based in New Haven, CT and was founded in 2016 by Dr. David Spiegel and Roy Prieb to translate Dr. Spiegel's research in small molecule immunotherapies at Yale University into clinical treatments. Kleo’s mission is to create fully synthetic compounds that recruit the immune system to destroy cancer cells, but with significant advantages compared to biologics. Kleo’s unique technologies are scientifically validated and proprietary. Proof of concept has been established in multiple in vitro and in vivo models, and the company’s technology and approach have been vetted by strategic investors Biohaven Pharmaceuticals and PeptiDream.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kleo PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    25 Science Park, Suite 235 New Haven, CT 06511
    Telephone
    Telephone
    (203)-691-6361
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kleopharmaceuticals.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology
    Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology

    07 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/biohaven-acquires-kleo-pharmaceuticals-and-licenses-platform-technology-from-yale-university-to-form-biohaven-labs-301202462.html

    PRNEWSWIRE
    07 Jan 2021
    Share Share
    Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology
    Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology

    07 Jan 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/biohaven-acquires-kleo-pharmaceuticals-and-licenses-platform-technology-from-yale-university-to-form-biohaven-labs/?s=79

    BIOSPACE
    07 Jan 2021
    Share Share
    Kleo Presents Preclinical Data on KPMW135, CD3 x CD20 Bispecific Rituximab
    Kleo Presents Preclinical Data on KPMW135, CD3 x CD20 Bispecific Rituximab

    07 Dec 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/fr/news-release/2020/12/07/2140728/0/en/Kleo-Pharmaceuticals-Presents-Preclinical-Data-on-KPMW135-a-Novel-CD3-x-CD20-Bispecific-Version-of-Rituximab-Showing-Increased-Anti-Tumor-Activity-Compared-to-Rituximab-at-The-62nd.html

    GLOBENEWSWIRE
    07 Dec 2020
    Share Share
    Kleo Pharmaceuticals to Present at “Bioscience Pipeline & Innovation
    Kleo Pharmaceuticals to Present at “Bioscience Pipeline & Innovation

    21 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/kleo-pharmaceuticals-to-present-at-bioscience-pipeline-and-innovation-in-connecticut-in-the-age-of-covid-conference/?s=73

    BIOSPACE
    21 Sep 2020
    Share Share
    Kleo Announces Orphan Drug Designation for KP1237 in Multiple Myeloma
    Kleo Announces Orphan Drug Designation for KP1237 in Multiple Myeloma

    08 Sep 2020

    // GLOBENEWS WIRE

    https://www.globenewswire.com/news-release/2020/09/08/2090094/0/en/Kleo-Pharmaceuticals-Announces-Orphan-Drug-Designation-for-KP1237-in-Multiple-Myeloma.html#:~:text=NEW%20HAVEN%2C%20Conn.%2C%20Sept,the%20U.S.%20Food%20and%20Drug

    GLOBENEWS WIRE
    08 Sep 2020
    Share Share
    Kleo Pharmaceuticals and Celularity Enter Research Collab Allogeneic NK Cell
    Kleo Pharmaceuticals and Celularity Enter Research Collab Allogeneic NK Cell

    21 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/21/2036946/0/en/Kleo-Pharmaceuticals-and-Celularity-Enter-into-Research-Collaboration-to-Rapidly-Develop-Allogeneic-NK-Cell-Combination-Therapies-for-COVID-19-and-Multiple-Myeloma.html

    GLOBENEWSWIRE
    21 May 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search